An early viral response to standard interferon-alpha identifies resistance to combination therapy with peginterferon and ribavirin in patients infected by HCV genotype 1-Reference-Cited by-同舟云学术

An early viral response to standard interferon-alpha identifies resistance to combination therapy with peginterferon and ribavirin in patients infected by HCV genotype 1

Published:2010-07-15 Issue:9 Volume:82 Page:1537-1544
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Toyoda Hidenori,Kumada Takashi,Kiriyama Seiki,Tanikawa Makoto,Hisanaga Yasuhiro,Kanamori Akira,Tada Toshifumi,Takagi Makiko,Hiramatsu Takeshi,Hosokawa Takanori,Arakawa Takahiro,Fujimori Masashi

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jmv.21858/fullpdf

Reference16 articles.

1. Prediction of treatment outcome in patients with chronic hepatitis C: Significance of baseline parameters and viral dynamics during therapy;Berg;Hepatology,2003

2. Extended treatment duration for hepatitis C virus type 1: Comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin;Berg;Gastroenterology,2006

3. Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon;Boulestin;J Med Virol,2006

4. Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin;Buti;Hepatology,2002

5. Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C;Davis;Hepatology,2003

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis;Journal of Gastroenterology;2016-02-12

2. Impact of genetic polymorphisms near the IL28B gene and amino acid substitutions in the hepatitis C virus core region on interferon sensitivity/resistance in patients with chronic hepatitis C;Journal of Medical Virology;2011-05-12